Statins and sepsis: multiple modifications at multiple levels
- 1 May 2007
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 7 (5), 358-368
- https://doi.org/10.1016/s1473-3099(07)70111-1
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases*Critical Care Medicine, 2007
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyBMJ, 2006
- Statin use and mortality within 180 days after bacteremia: A population-based cohort study*Critical Care Medicine, 2006
- Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1Biochemical and Biophysical Research Communications, 2004
- Simvastatin Prevents Vascular Hyporeactivity During InflammationCirculation, 2004
- Lymphocyte function antigen‐1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic miceBritish Journal of Pharmacology, 2004
- Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in miceGene Therapy, 2001
- Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain 1 1Edited by F. E. CohenJournal of Molecular Biology, 1999
- Plasma antioxidant potential in severe sepsisCritical Care Medicine, 1996
- Regulation of the mevalonate pathwayNature, 1990